# End-to-End Vaccine Cold Chain Visibility Platform

**Niche:** [[niches/cold-chain-logistics/vaccine-and-biologics-logistics/profile|Vaccine & Biologics Logistics]]
**Industry:** [[industries/cold-chain-logistics|Cold Chain Logistics]]
**Type:** Build (Greenfield Opportunity)
**One-liner:** No platform provides continuous temperature visibility and documentation from vaccine manufacturer through distributor through state depot through clinic — the full chain-of-custody that determines whether a $200 dose is viable or wasted.
**Tags:** #gradient-boosting #time-series-forecasting #data-integration #compliance #revenue-impact

## The Problem
Vaccine cold chain involves 3-5 handoff points between manufacturing and patient administration, each managed by a different organization with different monitoring systems. A vaccine lot ships from the manufacturer with a Sensitech logger, arrives at a distributor monitored by Controlant, transfers to a state health department warehouse with its own monitoring, and finally reaches a clinic with a standalone digital data logger (DDL) or, in many cases, no monitoring at all. At each handoff, the temperature record restarts — there is no continuous chain-of-custody temperature documentation from manufacture to administration. When a vaccine lot shows a potential excursion at any point, determining whether the product is viable requires manually assembling temperature records from every entity that handled it.

## Why Nobody Has Built This
Vaccine logistics involves public-sector procurement (CDC VFC program, state health departments) with complex stakeholder alignment requirements. Each handoff point uses different monitoring hardware, different data formats, and different organizational systems. Building end-to-end visibility requires data integration across entities that don't share IT infrastructure. The COVID-19 response highlighted this gap but emergency-use conditions prioritized speed over documentation infrastructure.

## What to Build
A multi-stakeholder cold chain visibility platform that creates a single temperature record per vaccine lot across all handoff points. Each participant (manufacturer, distributor, state depot, clinic) uploads or auto-syncs their monitoring data to a shared lot-level record. The platform validates temperature compliance at each stage, flags gaps in documentation, and provides a complete chain-of-custody report for any lot on demand. For ultra-cold products, the platform models dry ice sublimation rates to predict when replenishment is needed during transit and storage.

## Target Customer
Vaccine logistics directors at major distributors (McKesson, AmerisourceBergen, Cardinal Health), state immunization program managers, and biopharma companies managing clinical trial supply chains. Approximately 100-200 enterprise buyers plus 50 state/territory health departments.

## Impact If Built
Eliminates the vaccine waste caused by documentation gaps — estimated at $500M-$1B annually in the US from temperature-uncertain doses that must be discarded. Reduces the investigation time for suspected excursion events from days of multi-stakeholder record assembly to minutes of platform query. Enables proactive intervention when a lot's cumulative temperature exposure approaches its stability limit.
